| Long name: |
Cy5 Conjugated, CD300A/C Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
5, Cy5 |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
CD300A/C |
| Specificity: |
This is a highly specific antibody against CD300A/C |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen_range: |
20-70/299 |
| Subcellular location: |
Extracellular |
| Source: |
KLH conjugated synthetic peptide derived from human CD300A |
| Gene ID number: |
11314 |
| Swiss Prot: |
Q9UGN4 |
| Tested applications: |
IF(IHC-P), FCM |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), FCM(1:20-100) |
| Crossreactivity: |
Human |
| Crossreactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: |
and to the down-regulation of mast cell degranulation, Inhibitory receptor which may contribute to the down-regulation of cytolytic activity in natural killer (NK) cells |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
625, 650nm/670nm |
| Synonyms: |
Irp60 CMRF35H CMRF-35-H9 IRC1 IRC2 IGSF12 |
| Properties: |
Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
CD300A/C Conjugated |
| Short name: |
Conjugated, CD300A/C Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
Cy5 |
| Alternative name: |
cyanine 5 coupled, CD300a molecule/C (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CD300A and IDBG-67271 and ENSG00000167851 and 11314, CLM-8 and CMRF-35-H9 and CMRF-35H and CMRF35-H and CMRF35-H9 and CMRF35H and CMRF35H9 and IGSF12 and IRC1 and IRC1/IRC2 and IRC2 and IRp60, Plasma membranes, engulfment and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :1902564 and negative regulation of neutrophil activation and biological process this GO :1902567 and negative regulation of eosinophil activation and biological process this GO :1902569 and negative regulation of activation of JAK2 kinase activity and biological process this GO :2000417 and negative regulation of eosinophil migration and biological process, signaling receptor activity, this GO :0001786 and phosphatidylserine binding and molecular function this GO :0002376 and immune system process and biological process this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0007155 and cell adhesion and biological process this GO :0007165 and signal transduction and biological process this GO :0008429 and phosphatidylethanolamine binding and molecular function this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0030889 and negative regulation of B cell proliferation and biological process this GO :0032516 and positive regulation of phosphoprotein phosphatase activity and biological process this GO :0033007 and negative regulation of mast cell activation involved in immune response and biological process this GO :0038023 and signaling receptor activity and molecular function this GO :0043305 and negative regulation of mast cell degranulation and biological process this GO :0043407 and negative regulation of MAP kinase activity and biological process this GO :0045087 and innate immune response and biological process this GO :0048147 and negative regulation of fibroblast proliferation and biological process this GO :0050856 and regulation of T cell receptor signaling pathway and biological process this GO :0050859 and negative regulation of B cell receptor signaling pathway and biological process this GO :0051134 and negative regulation of NK T cell activation and biological process this GO :0060101 and negative regulation of pha this GO cytosis, this GO :0001786 : phosphatidylserine binding, this GO :0001786 : phosphatidylserine binding and also this GO :0005515 : protein binding and also this GO :0008429 : phosphatidylethanolamine binding and also this GO :0038023 : signaling receptor activity, this GO :0005515 : protein binding, this GO :0008429 : phosphatidylethanolamine binding, this GO :0038023 : signaling receptor activity, CD300a molecule |
| Identity: |
19319 |
| Gene: |
CD300A |
More about : CD300A |
| Long gene name: |
CD300a molecule |
| Synonyms gene name: |
CD300a antigen |
| Locus: |
17q25, 1 |
| Discovery year: |
2005-02-08 |
| GenBank acession: |
BC032352 |
| Entrez gene record: |
11314 |
| Pubmed identfication: |
9701027 10746781 |
| RefSeq identity: |
NM_007261 |
| Classification: |
CD molecules V-set domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000067612 |